Growth Metrics

Viemed Healthcare (VMD) EPS (Weighted Average and Diluted) (2018 - 2026)

Viemed Healthcare filings provide 8 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.14 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 27.27% to $0.14 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.37, a 27.59% increase, with the full-year FY2025 number at $0.37, up 32.14% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.14 in Q4 2025 for Viemed Healthcare, up from $0.09 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.14 in Q4 2025 to a low of $0.02 in Q2 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.06 (2023), compared with a mean of $0.06.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 91.67% in 2021 and later skyrocketed 200.0% in 2023.
  • Viemed Healthcare's EPS (Weighted Average and Diluted) stood at $0.1 in 2021, then decreased by 30.0% to $0.07 in 2022, then increased by 14.29% to $0.08 in 2023, then soared by 37.5% to $0.11 in 2024, then increased by 27.27% to $0.14 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.14 (Q4 2025), $0.09 (Q3 2025), and $0.08 (Q2 2025) per Business Quant data.